ArticleSpringerPlus2014

The 24-h FEV1 time profile of olodaterol once daily via Respimat® and formoterol twice daily via Aerolizer® in patients with GOLD 2-4 COPD: results from two 6-week crossover studies.

Gregory J Feldman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.